The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-03
DOI
10.1007/s11010-023-04793-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment
- (2022) Mathilde M.H. Pauls et al. Alzheimers & Dementia
- Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
- (2022) Hayder M. Al-Kuraishy et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
- (2022) Gomaa Mostafa-Hedeab et al. INFLAMMOPHARMACOLOGY
- Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress
- (2022) Mohammed Alorabi et al. BIOMEDICINE & PHARMACOTHERAPY
- Quercetin-3-O-β-D-Glucopyranoside-Rich Fraction from Spondias mombin Leaves Halted Responses from Oxidative Stress, Neuroinflammation, Apoptosis, and Lipid Peroxidation in the Brain of Dichlorvos-Treated Wistar Rats
- (2022) Olalekan Bukunmi Ogunro et al. Toxics
- Biochemical and tissue physiopathological evaluation of the preclinical efficacy of Solanum torvum Swartz leaves for treating oxidative impairment in rats administered a β-cell-toxicant (STZ)
- (2022) Saidu Sani et al. BIOMEDICINE & PHARMACOTHERAPY
- Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
- (2022) Gaber El-Saber Batiha et al. Diabetology & Metabolic Syndrome
- The role of berberine in Covid-19: potential adjunct therapy
- (2022) Ahmad O. Babalghith et al. INFLAMMOPHARMACOLOGY
- Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
- (2022) Asma W. Al-Thomali et al. Biomedicines
- Montelukast and Acute Coronary Syndrome: The Endowed Drug
- (2022) Basil Mohammed Alomair et al. Pharmaceuticals
- Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis
- (2022) Malcolm Marquette et al. CURRENT ALLERGY AND ASTHMA REPORTS
- PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
- (2021) Claire Lugnier et al. BIOCHEMICAL PHARMACOLOGY
- Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells
- (2021) Pan M Liy et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
- (2021) Hayder M. Al-kuraishy et al. Frontiers in Medicine
- From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
- (2021) Mohammad Abdel-Halim et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of intranasal guanosine administration on brain function in a rat model of ischemic stroke
- (2021) Gabriel C. Müller et al. Purinergic Signalling
- Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats
- (2021) Walaa Wadie et al. LIFE SCIENCES
- The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
- (2021) Dean Paes et al. PHARMACOLOGICAL REVIEWS
- TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats
- (2021) Francesca E. Mowry et al. PHARMACOLOGICAL RESEARCH
- Sildenafil-Mediated Neuroprotection from Adult to Neonatal Brain Injury: Evidence, Mechanisms, and Future Translation
- (2021) Manuela Zinni et al. Cells
- Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease
- (2020) Elisa Zuccarello et al. BIOCHEMICAL PHARMACOLOGY
- Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review
- (2020) Seung-Woo Kim et al. Cells
- Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States
- (2020) Wei Liu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Role of NLRP3 Inflammasomes in Neuroinflammation Diseases
- (2020) Sen Lin et al. EUROPEAN NEUROLOGY
- Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
- (2019) Aldenor G. Santos et al. Scientific Reports
- Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review
- (2019) Saiqa Yasmeen et al. CELLULAR SIGNALLING
- 015 Dual inhibition by phosphodiesterase-5 and 5-HT2B inhibitors leads to near complete amelioration of fibrotic potential of human dermal fibroblasts from scleroderma patients
- (2019) Vikas Agarwal et al. RHEUMATOLOGY
- Neuroinflammation: friend and foe for ischemic stroke
- (2019) Richard L. Jayaraj et al. Journal of Neuroinflammation
- cGMP-dependent protein kinase I in vascular smooth muscle cells improves ischemic stroke outcome in mice
- (2019) Maria Shvedova et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy
- (2019) Maria Eduarda Rocha França et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review
- (2019) Hossein Bagheri et al. BIOFACTORS
- PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
- (2018) K-E Andersson BRITISH JOURNAL OF PHARMACOLOGY
- Inflammasomes: a novel therapeutic target in pulmonary hypertension?
- (2018) Tara Elizabeth Scott et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective mechanisms of sildenafil and selenium in PTZ-kindling model: Implications in epilepsy
- (2018) Karim M. Tawfik et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction
- (2018) Xiao Li et al. MEDICINE
- Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery
- (2018) Michael A. Hollas et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease
- (2018) Mariana M. Clavé et al. Congenital Heart Disease
- Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer’s Disease
- (2017) Min Sheng et al. JOURNAL OF ALZHEIMERS DISEASE
- The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review
- (2017) Mathilde MH Pauls et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
- (2017) Gülru Kayık et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats
- (2016) Caixia Yin et al. NEUROSCIENCE
- Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy
- (2016) Ulrich Lindberg et al. Neurotherapeutics
- Imaging Neuroinflammation in Ischemic Stroke and in the Atherosclerotic Vascular Disease
- (2015) Chiara Cerami et al. Current Vascular Pharmacology
- Phosphodiesterase type 5 inhibitors and kidney disease
- (2015) Baris Afsar et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors
- (2015) Edgar R. Wood et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model
- (2015) Lei Zhu et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
- (2015) Christina Alves Peixoto et al. MEDIATORS OF INFLAMMATION
- PDE5 inhibition improves acquisition processes after learning via a central mechanism
- (2015) S. Akkerman et al. NEUROPHARMACOLOGY
- PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
- (2015) Anindita Das et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke
- (2015) Adrià Arboix World Journal of Clinical Cases
- Regional cerebral blood flow following single-dose and continuous-dose tadalafil after stroke
- (2014) M. Lorberboym et al. ACTA NEUROLOGICA SCANDINAVICA
- Repeated daily dosing with sildenafil provides sustained protection from endothelial dysfunction caused by ischemia and reperfusion: a human in vivo study
- (2014) Kelsey McLaughlin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Tadalafil enhances the neuroprotective effects of ischemic postconditioning in mice, probably in a nitric oxide associated manner
- (2014) Puja Gulati et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- The L-arginine Pathway in Acute Ischemic Stroke and Severe Carotid Stenosis: Temporal Profiles and Association with Biomarkers and Outcome
- (2014) Tihamer Molnar et al. Journal of Stroke & Cerebrovascular Diseases
- Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases
- (2014) Mehdi Ghasemi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Sildenafil Mediates Blood-Flow Redistribution and Neuroprotection After Neonatal Hypoxia-Ischemia
- (2014) Christiane Charriaut-Marlangue et al. STROKE
- Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice
- (2013) Junfang Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- PDE5 inhibitors: considerations for preference and long-term adherence
- (2013) W. B. Smith et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction
- (2013) Marisol Godínez-Rubí et al. Oxidative Medicine and Cellular Longevity
- Recurrent ischemic stroke associated with sildenafil and tadalafil use in a young adult
- (2012) Maja Stefanović-Budimkić et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model
- (2012) Ana Karolina de Santana Nunes et al. CYTOKINE
- Nitric Oxide: Considerations for the Treatment of Ischemic Stroke
- (2012) Nicole A Terpolilli et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD
- (2012) Carolina García-Barroso et al. NEUROPHARMACOLOGY
- Inhaled Nitric Oxide Reduces Brain Damage by Collateral Recruitment in a Neonatal Stroke Model
- (2012) Christiane Charriaut-Marlangue et al. STROKE
- Dysfunction of the endothelial-platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil
- (2011) S. La Vignera et al. ANDROLOGIA
- Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: A pilot study
- (2011) Tomomi Nakamura et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effects of the PDE5-inhibitor vardenafil in a mouse stroke model
- (2009) Georg Royl et al. BRAIN RESEARCH
- Evaluation of inhaled NO in a model of rat neonate brain injury caused by hypoxia–ischaemia
- (2009) Sylvie Joriot-Chekaf et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Sildenafil Treatment of Subacute Ischemic Stroke: A Safety Study at 25-mg Daily for 2 Weeks
- (2009) Brian Silver et al. Journal of Stroke & Cerebrovascular Diseases
- Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion
- (2008) Letizia Corsani et al. EXPERIMENTAL NEUROLOGY
- Magnetic Resonance Imaging Investigation of Axonal Remodeling and Angiogenesis after Embolic Stroke in Sildenafil-Treated Rats
- (2008) Guangliang Ding et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Additive Effects of Statin and Dipyridamole on Cerebral Blood Flow and Stroke Protection
- (2008) Hyung-Hwan Kim et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Tadalafil improves short-term memory by suppressing ischemia-induced apoptosis of hippocampal neuronal cells in gerbils
- (2008) Il-Gyu Ko et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now